J&J to stop selling opioids in US

&j agrees to stop selling opioids in the us
&j agrees to stop selling opioids in the us

WASHINGTON: US pharmaceutical giant Johnson & Johnson will “exit from the opioid business nationally” as part of a $230 million settlement with New York, the state´s attorney general Letitia James said Saturday.

The agreement allows Johnson & Johnson to resolve litigation over its “role in helping to fuel the opioid epidemic,” according to a statement from the prosecutor, who said the company would spread the payments over nine years.

It could also pay an additional $30 million in the first year if the state enacts new legislation creating an opioid settlement fund.

The company still faces other legal proceedings nationwide, including an ongoing trial in California.

“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in the statement.

“Johnson & Johnson helped fuel this fire, but today they´re committing to leaving the opioid business — not only in New York, but across the entire country,” she added.

That includes both manufacturing and selling opioids, the statement said

&j agrees to stop selling opioids in the us
&j agrees to stop selling opioids in the us